Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

UTI Innovation Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

UTI Innovation FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseUTIHDFC
NAV₹11.0545₹22.8170
NAV date20 Nov 202620 Nov 2026
History3.1 years3.1 years
Expense ratio2.4%2.1%
Stars★★★★★★★★★★
Growth Score3.4093.90

Returns

UTI Innovation FundHDFC Pharma and Healthcare Fund
1 month+1.66%+12.87%
3 months−7.43%+6.85%
6 months+5.31%+17.20%
YTD−3.75%+32.43%
1 year−6.79%+30.73%
3 years (CAGR)+1.91%+29.16%
5 years (CAGR)——
10 years (CAGR)——
Since launch+3.24%+30.28%

Risk

UTI Innovation FundHDFC Pharma and Healthcare Fund
Volatility21.0%15.8%
Downside volatility14.9%8.6%
Sharpe−0.221.44
Sortino−0.312.64
Calmar0.061.94
Return / risk0.091.85
Deepest fall−32.94%−15.07%
Days to recover—133
Below its high−16.48%+0.00%

Against benchmark

UTI Innovation FundHDFC Pharma and Healthcare Fund
Alpha−8.02%+6.36%
Beta1.010.97
R²59.6%85.0%
Up capture77.5%106.7%
Down capture118.9%74.4%
Tracking error13.3%6.1%
Information ratio−0.600.97
Treynor−0.050.22

Consistency

UTI Innovation FundHDFC Pharma and Healthcare Fund
Best 1-year+27.21%+64.96%
Middle 1-year−2.94%+21.84%
Worst 1-year−15.00%+0.52%
1-year periods with a loss67.6%0.0%
Middle 3-year+2.74%+28.68%
Positive months52.8%69.4%
Best day+4.67%+3.19%
Worst day−4.43%−3.62%
Worst 5% day−2.03%−1.50%
Positive days54.7%58.1%
NAVs a year247247

SIP of ₹10,000 a month

UTI Innovation FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR−0.09%+26.26%
1-year XIRR+4.00%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth